Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;38(1):55-62.
doi: 10.3109/00952990.2011.600389. Epub 2011 Aug 11.

The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs

Affiliations

The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs

Kora DeBeck et al. Am J Drug Alcohol Abuse. 2012 Jan.

Abstract

Background: Innovative health programs for injection drug users (IDUs), such as supervised injecting facilities (SIFs), are often preceded by evaluations of IDUs' willingness to use the service. The validity of these surveys has not been fully evaluated. We sought to determine whether measures of willingness collected prior to the opening of a Canadian SIF accurately predicted subsequent use of the program.

Methods: Data were derived from a prospective cohort of IDUs. The sample size for this study was 640 IDUs. Using multivariate logistic regression, it was assessed if a history of reporting willingness to use the program, were it available, was associated with subsequent use. In sub-analysis restricted to individuals who had a history of reported willingness, we used multivariate longitudinal analysis to identify factors associated with not attending the SIF.

Results: Among 442 IDUs, 72% of those who reported initial willingness to use a SIF later attended the program, and a prior willingness to use a SIF significantly predicted later attendance (adjusted odds ratio = 1.67). In sub-analyses restricted to those who had a history of reporting willingness to use the SIF, not using the program was predicted by not frequenting the neighborhood where the SIF was located.

Conclusion: Our findings indicate that reported willingness measures collected from IDUs regarding potential SIF program participation prior to its opening independently predicted later attendance even when variables that were likely determinants of willingness were adjusted for. These data suggest that willingness measures are reasonably valid tools for planning the delivery of health services among IDU populations.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

Dr. Julio Montaner has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by Abbott, Argos Therapeutics, Bioject Inc., Boehringer Ingelheim, Bristol-Myers Squibb (BMS), Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck Frosst, Pfizer, Schering, Serono Inc., TheraTechnologies, Tibotec, and Trimeris. The authors declare no other competing interests.

Figures

FIGURE 1
FIGURE 1
Study sample. Note: SIF, supervised injection facility.

Similar articles

Cited by

References

    1. DeBeck K, Wood E, Montaner J, Kerr T. Canada’s 2003 renewed drug strategy – An evidence-based review. HIV AIDS Policy Law Rev. 2006;11(2–3):1, 5–12. - PubMed
    1. Reuter P, Caulkins J. Redefining the goals of national drug policy: Recommendations from a working group. Am J Public Health. 1995;85(8 Pt 1):1059. - PMC - PubMed
    1. Rhodes T. ‘The risk environment’: A framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.
    1. Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JSG, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev. 2008;27(3):270–276. - PMC - PubMed
    1. Rowden D, Dorsey P, Bullman S, Lestina R, Han C, Herrell J. HIV outreach for hard-to-reach populations: A cross-site perspective. Eval Program Plann. 1999;22(3):251–258. - PubMed

Publication types

LinkOut - more resources